Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Stryker Rejuvenate Settlement Reached in Another Hip Lawsuit January 31, 2014 Austin Kirk Add Your Comments As a result of mediation efforts in New Jersey state court, an agreement has been reached to settle at least one more Stryker Rejuvenate hip lawsuit during the early stages of the litigation process, meaning that five out of the eight cases that have gone through the court-ordered mediation process so far have resolved. There are currently about 1,200 product liability lawsuits filed throughout the country by individuals who experienced problems after receiving a Stryker Rejuvenate or ABG II modular hip implant, which were recalled in July 2012, amid reports that the design was prone to fail within a few years. Approximately half of the cases filed nationwide are pending in the U.S. District Court for the District of Minnesota, where the federal lawsuits are centralized for pretrial proceedings before U.S. District Judge Donovan Frank as part of an MDL, or Multidistrict Litigation. Learn More About Hip Replacement Lawsuits If you or a loved one experienced complications or needed revision surgery due to a defective hip implant, you may be entitled to financial compensation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Hip Replacement Lawsuits If you or a loved one experienced complications or needed revision surgery due to a defective hip implant, you may be entitled to financial compensation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION About 650 of the cases are pending in New Jersey state court, which is location of the headquarters for Howmedica Osteonics Corp., the parent company for Stryker. The New Jersey litigation has also been centralized for pretrial proceedings, with all of the cases filed throughout the state consolidated before Judge Brian R. Martinotti in Bergen County. In an attempt to see if cases can be resolved before lengthy and expensive litigation, Judge Martinotti has established a mediation process last year in the New Jersey litigation. As part of the first phase of this Stryker Rejuvenate mediation, a group of 10 cases were selected for early settlement negotiations. In December 2013, the Court reported that six mediations had been completed, with agreements to settle four cases reached. One additional matter originally set for mediation was withdrawn at that time, because the plaintiff was continuing to receive medical treatment for problems with the Stryker hip, leaving three cases in the first mediation phase. According to a new Order (PDF) issued by Judge Martinotti on January 28, two additional mediations have now been held, with one of the cases settling and discussions continuing in the other case. In addition, the parties are in the process of securing a date to discuss settlement in the third matter. While the first phase of case mediations are being completed, Judge Martinotti is starting the process for a “Phase II”, ordering the parties to submit a list of cases that will be eligible for this second round of mediation by February 4. The Court will then announce the final selections by February 11. Those mediations will be scheduled for dates in the second half of March and April 2014. Before the Stryker Rejuvenate and ABG II implants were removed from the market in July 2012, an estimated 20,000 components were sold. Therefore, as additional Stryker hips fail, it is ultimately expected that several thousand case will be brought in state and federal courts throughout the United States. Unlike traditional hip implants, which feature a single femoral component, the Stryker Rejuvenate and ABG II contain a modular neck-stems, which consists of two pieces that fit inside each other to allow the surgeon to customize the length of the femoral component based on the patient. However, the design has been linked to an increased risk of problems that may result from the release of microscopic metal debris as the chromium-cobalt neck rubs against the titanium femoral stem. Although hip replacements are expected to last 15 to 20 years, the Stryker Rejuvenate recall was issued less than two years after the design was introduced. While details have not been released about the terms of the Stryker settlements reached in the five cases that have resolved so far, Howmedica estimated in its third-quarter earnings report last year that the total costs associated with the recall and Stryker Rejuvenate settlements may exceed $1 billion. Tags: Hip Replacement System, Stryker, Stryker ABG II, Stryker Rejuvenate Image Credit: | More Hip Replacements Lawsuit Stories Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant December 26, 2024 Zimmer Biomet Lawsuit Filed Over RibFix Blu Implant Fracture September 25, 2024 Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)